Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa-Reference-Cited by-同舟云学术

Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa

Published:2023-04 Issue:4 Volume:58 Page:619-623
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Oldakovskiy Vladislav^ORCID,Murashkin Nikolay,Lokhmatov Maksim,Gusev Aleksey^ORCID,Tupylenko Artem^ORCID,Budkina Tatiana^ORCID,Yatzik Sergey,Dyakonova Elena,Abaykhanov Rasul,Fisenko Andrey

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Reference31 articles.

1. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification;Fine;J Am Acad Dermatol [Internet].,2014

2. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility;Has;Br J Dermatol,2020

3. The clinical spectrum of dystrophic epidermolysis bullosa;Horn;Br J Dermatol,2002

4. Oral and gastrointestinal manifestations of epidermolysis bullosa;Travis;Lancet,1992

5. The importance of esophagography in patients with recessive dystrophic epidermolysis bullosa;Guerra-Leal;Am J Roentgenol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anesthesia management for patients with congenital epidermolysis bullosa: A challenge case report for the anesthesiologist;International Journal of Surgery Case Reports;2024-09

2. Epidermolysis Bullosa: A Review of Wound Care and Emerging Treatments;Current Dermatology Reports;2024-07-30

3. Paclitaxel-coated balloon catheter for benign esophageal stenosis in a rabbit model;Scientific Reports;2024-01-31

4. INOVAÇÕES NO MANEJO CLÍNICO DA EPIDERMÓLISE BOLHOSA DISTRÓFICA;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-01-20

5. Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects;Therapeutics and Clinical Risk Management;2023-06